Implementation facilitators and barriers to the expansion of a peer-led overdose prevention program

被引:1
作者
Perreault, Michel [1 ,2 ,4 ]
Ferlatte, Marie-Anne [1 ]
Lachapelle, Elise [1 ]
Tremblay, Guillaume [3 ]
Milton, Diana [1 ]
机构
[1] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada
[2] McGill Univ, Dept Psychiat, Montreal, PQ, Canada
[3] Meta Ame, Montreal, PQ, Canada
[4] Douglas Mental Hlth Univ Inst, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada
关键词
Opioids; overdose prevention; facilitators; barriers; implementation; peers; TAKE-HOME NALOXONE; OPIOID OVERDOSE; BENEFITS;
D O I
10.1080/09687637.2023.2178880
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
In Canada, there has been a substantial increase of opioid overdoses in recent years. PROFAN, a peer-led overdose prevention initiative, was successfully implemented in Montreal, Quebec, for people who use drugs (PWUD), or those likely to witness overdoses. The worsening of the situation during the COVID-19 pandemic sparked the need to expand the program across the province. Individual interviews were conducted with 17 key informants from 12 health regions to identify implementation facilitators and barriers. A thematic analysis was conducted based on emerging themes. Four main facilitators were reported: 1) presence of an active peer network involved with harm reduction in the region, 2) collaboration among community and public health sectors, 3) stakeholders' awareness of opioid situation, and 4) perceived appropriateness of training. Six main barriers also emerged: 1) geographical isolation, 2) existing offer of similar services, 3) difficulty reaching isolated PWUD, 4) stigmatization of PWUD, 5) unwillingness of stakeholders to address situation, and 6) lack of funding stability. The expansion achieved by the PROFAN program highlights the ability of a peer-driven community organization to lead an overdose prevention program when provided with funding and support from government health agencies and partnerships with other organizations such as addiction worker associations.
引用
收藏
页码:212 / 220
页数:9
相关论文
共 45 条
[11]   Sociodemographic Characteristics and the Stigmatization of Prescription Opioid Addiction [J].
Goodyear, Kimberly ;
Chavanne, David .
JOURNAL OF ADDICTION MEDICINE, 2020, 14 (02) :150-155
[12]  
Government of Canada, 2021, Opioidand stimulant related harms in Canada
[13]  
Government of Canada, 2021, MESURES FEDERALES OP
[14]  
Government of Canada, 2018, DRUG ANAL SERVICE SU
[15]  
Guijt I., 2014, METHODOLOGICAL BRIEF, V5
[16]   Preventing opioid overdose with peer-administered naloxone: findings from a rural state [J].
Hanson, Bridget L. ;
Porter, Rebecca R. ;
Zold, Amanda L. ;
Terhorst-Miller, Heather .
HARM REDUCTION JOURNAL, 2020, 17 (01)
[17]   Stakeholders' Perceptions of Factors Influencing the Use of Take-Home-Naloxone [J].
Holland, Taylor J. ;
Penm, Jonathan ;
Johnson, Jacinta ;
Sarantou, Maria ;
Chaar, Betty B. .
PHARMACY, 2020, 8 (04) :1-28
[18]  
Institut national de sante publique du Quebec, 2022, DECES RELIES INTOXIC
[19]  
Institut national de sante publique du Quebec, 2021, DECES RELIES INTOXIC
[20]   Take-Home Naloxone and the Need for a Publicly Funded Naloxone Supply COMMENT [J].
Kim, Howard S. ;
Aks, Steven E. .
JOURNAL OF ADDICTION MEDICINE, 2022, 16 (01) :1-3